Platelet-activating factor (PAF) in experimental and clinical sepsis

Shock
G MathiakR Rabinovici

Abstract

Despite considerable progress in understanding the pathogenic mechanisms of Gram-negative sepsis, the outcome of septic patients has not significantly improved. There are ample data that support a role for inflammatory mediators in sepsis that act in synergy with infectious agents to initiate and propagate the disease process. One such mediator is the glycerophospholipid platelet-activating factor (PAF). The objective of the present review is to summarize experimental and clinical evidence implicating PAF as a mediator in the pathomechanism of sepsis. This review is timely because many potent and selective PAF antagonists have matured for clinical development and a careful analysis of the data that support or refute the merit of clinical trials with such compounds may be important for both academic and pharmaceutical applications.

Citations

Jan 8, 2000·The Surgical Clinics of North America·L M NapolitanoR Coimbra
Jul 19, 2002·Chest Surgery Clinics of North America·Steven A Conrad, Akhil Bidani
May 12, 2000·Critical Care Medicine·E M Bulger, R V Maier
Oct 19, 2002·Current Opinion in Critical Care·Guillermo Domínguez-CheritEduardo Rivero-Sigarroa
Feb 6, 2004·Critical Care Medicine·Steven OpalUNKNOWN Controlled Mortality Trial of Platelet-Activating Factor Acetylhydrolase in Severe Sepsis Investigators
Apr 22, 2003·Infection and Immunity·Murray W StinsonSarmishtha Kumar
Dec 1, 2009·Journal of Pediatric Surgery·Nicholas EvennettSimon Eaton
Oct 20, 2001·Disease-a-month : DM·P E Marik, J Varon
Nov 3, 2005·Neuroscience Letters·Tetsuya KushikataJames M Krueger
Oct 28, 2003·The American Journal of Pathology·Michal A ElovitzMark Phillippe
Jun 9, 2015·The Journal of Allergy and Clinical Immunology·Parwinder GillPeter Vadas
May 11, 2002·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·L M McManus, R N Pinckard
Jun 18, 2005·Memórias do Instituto Oswaldo Cruz·Hugo C Castro Faria NetoGuy A Zimmerman
Jan 31, 2014·The Journal of Biological Chemistry·Johanna RiveraDavid L Goldman
Jun 18, 2003·The Journal of Biological Chemistry·Junji WatanabeThomas M McIntyre
Apr 11, 2006·Clinical and Vaccine Immunology : CVI·Ho Seong SeoMoon H Nahm
May 15, 2018·Nutrients·Alexandros TsouprasIoannis Zabetakis
Nov 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Patrícia PachecoPatrícia T Bozza
Oct 19, 2017·Scientific Reports·Ingmar LautenschlägerStefan Uhlig
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Susana E MorenoMauro M Teixeira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.